AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34052943
Drug: Deep sedation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep sedation (DS) with propofol and sufentanil (0.05 mg/kg)
Trial: 32831908
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg of Vitamin K2 + a calcinated magnesium placebo (n = 12)
Trial: 32831908
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU vitamin D3 + 100 μg vitamin K2 (n = 12)
Trial: 36285519
Drug: Dalpiciclib 100
RxNorm normalized name: Dalpiciclib
DrugBank: Dalpiciclib (DB17456)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalpiciclib 100 mg
Trial: 36285519
Drug: Dalpiciclib 125
RxNorm normalized name: Dalpiciclib
DrugBank: Dalpiciclib (DB17456)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalpiciclib 125 mg
Trial: 36285519
Drug: Dalpiciclib 150
RxNorm normalized name: Dalpiciclib
DrugBank: Dalpiciclib (DB17456)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalpiciclib 150 mg
Trial: 33710347
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual with additional differential treatment component
Trial: 33066869
Drug: Methylcobalamin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcobalamin (500 mcg/day)
Trial: 33066869
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg/day) + Methylcobalamin (500 mcg/day)
Trial: 33066869
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral anti-diabetic drugs
Trial: 35533490
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy applied before deep breathing and coughing exercises
Trial: 32479544
Drug: Lifestyle (LS)
RxNorm normalized name: bisoprolol fumarate Oral Tablet [Emcor LS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle (LS) programme with CBT, healthy diet, and physical therapy
Trial: 33109859
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 μg/kg/h
Trial: 33109859
Drug: Dexmedetomidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.5 μg/kg/h
Trial: 36362704
Drug: Proactive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive therapy (intermittent use of a very strong topical corticosteroid for 4 weeks)
Trial: 36362704
Drug: Rank-down therapy
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rank-down therapy (daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks)
Trial: 36362704
Drug: Rank-down therapy
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rank-down therapy
Trial: 36362704
Drug: Proactive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive therapy
Trial: 33017662
Drug: Salvage chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvage chemotherapy (post-allo-HSCT)
Trial: 36045468
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of essential oils and 0.12% chlorhexidine mouthwash
Trial: 37494942
Drug: Bictegravir (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bictegravir (50 mg), Emtricitabine (200 mg), Tenofovir Alafenamide (25 mg)
Trial: 35483297
Drug: Sham AurPrs
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham AurPrs treatment
Trial: 33875811
Drug: Stoss therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stoss therapy (single high-dose oral vitamin D therapy) plus weekly/daily supplementation
Trial: 32663945
Drug: Deceptive active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deceptive active placebo via intranasal application with expectancy-enhancing instructions
Trial: 32303737
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAC) injections (10 mg/ml), with up to three injections administered over 12 weeks (initial injection, followed by two additional injections 6 weeks apart).
Trial: 32303737
Drug: TAC injections
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TAC injections (10 mg/ml).
Trial: 33298143
Drug: Cefixime 400
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 400 mg orally twice a day for 10 days
Trial: 33298143
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin G 2.4 M IU intramuscularly once
Trial: 32389377
Drug: Fully guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fully guided protocol with cylindrical guiding holes (12 implants)
Trial: 32389377
Drug: Fully guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fully guided protocol with C-shaped guiding holes (12 implants)
Trial: 32389377
Drug: Partially guided
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially guided protocol with cylindrical guiding holes (12 implants)
Trial: 32389377
Drug: Partially guided
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially guided protocol with C-shaped guiding holes (12 implants)
Trial: 33211352
Drug: Topical 0.5%
RxNorm normalized name: phenol topical 0.5% topical spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.5% timolol maleate (TM) applied to one cheek
Trial: 35268024
Drug: Gummy L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gummy L. plantarum Dad‐13 (108‐9 CFU/3 g) for 50 days
Trial: 32798463
Drug: Delayed stenting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed stenting (after 24 to 48 hours with antithrombin therapy)
Trial: 36280151
Drug: Accelerated hypofractionated
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated hypofractionated radiotherapy (1.8 Gy daily to PTV with a 0.6 Gy boost to GTV, total 45 Gy to PTV and 60 Gy to GTV in 25 fractions over 5 weeks)
Trial: 36280151
Drug: Conventional fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionated radiotherapy (2 Gy daily to PTV, total 44 Gy to PTV and 60 Gy to GTV in 30 fractions over 6 weeks)
Trial: 32162822
Drug: Physician's choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician's choice of chemotherapy (PCT)
Trial: 33947729
Drug: Episodic adalimumab
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Episodic adalimumab monotherapy (24 weeks)
Trial: 32423429
Drug: Onkyeong-tang (OKT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onkyeong-tang (OKT), 3 g orally three times per day for 8 weeks
Trial: 32423429
Drug: Placebo, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 3 g orally three times per day for 8 weeks
Trial: 32756091
Drug: Liuwei Dihuang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liuwei Dihuang pills (LDP)
Trial: 34820771
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day rosuvastatin for 6 months
Trial: 36272926
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy combined with nutritional supplementation (Ex + Nutr; n = 29)
Trial: 36272926
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy alone (Ex; n = 29)
Trial: 33899934
Drug: Various dosing
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various dosing regimen optimization strategies for ADCs including body weight cap dosing, treatment duration capping, dose schedule adjustments, response-guided dosing recommendations, and randomized dose-finding.
Trial: 32488891
Drug: Botulinum toxin-A
RxNorm normalized name: Botulinum toxin A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Botulinum toxin-A (BTX-A) injection and a home-based exercise program
Trial: 34167656
Drug: Active tDCS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active tDCS (5 daily sessions, 1mA for 20min over parieto-occipital regions)
Trial: 34494088
Drug: Lactulose (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (20 g)
Trial: 33933751
Drug: Intravenous fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fish oil (IV-FO)
Trial: 32772873
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine (50 mg)
Trial: 32585077
Drug: Differentiated service
RxNorm normalized name: SYRINGE SERVICES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Differentiated service delivery (DSD) model implementation including repeat prescription collection strategies (RPCS)
Trial: 32585077
Drug: Enhanced counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced counselling and tracing patients lost-to-follow-up for patients not stable on treatment
Trial: 34738278
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia + LLLT (diode laser: 810 nm; continuous mode; 0.3W; 20 s; 69 J/cm2)
Trial: 34738278
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia + LLLT
Trial: 35905275
Drug: Chlorhexidine digluconate
RxNorm normalized name: Chlorhexidine digluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine digluconate lozenges
Trial: 33477165
Drug: Reflexology applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reflexology applied for 20 min (10 min for each foot) twice a day with 8-hour intervals on the first and second days after CS
Trial: 33835715
Drug: Vancomycin trough
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin trough concentration (VTC) less than 10 mg/L
Trial: 33835715
Drug: Vancomycin trough
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin trough concentration (VTC) 10–15 mg/L
Trial: 33835715
Drug: Vancomycin trough
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin trough concentration (VTC) 15–20 mg/L
Trial: 33835715
Drug: Vancomycin trough
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin trough concentration (VTC) greater than 20 mg/L
Trial: 97266229
Drug: Insulin administration
RxNorm normalized name: insulin administration supplies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin administration during hyperglycaemic conditions
Trial: 97266229
Drug: Insulin administration
RxNorm normalized name: insulin administration supplies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin administration during normoglycaemic conditions
Trial: 97266229
Drug: Insulin administration
RxNorm normalized name: insulin administration supplies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin administration in normal subjects
Trial: 35791476
Drug: Garlic (KWAI)
DrugBank: Garlic (DB10532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic (KWAI) 300 mg daily in doses of 0.3g, 0.6g, 0.9g, 1.2g, and 1.5g for 24 weeks
Trial: 35791476
Drug: Simvastatin (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (standard lipid-lowering agent)
Trial: 35333803
Drug: Anal bulking
RxNorm normalized name: Mephitis mephitis anal gland fluid preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anal bulking agent with polyacrylate‐polyalcohol copolymer particles
Trial: 32448336
Drug: Intravenous buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous buprenorphine (0.02 mg/kg)
Trial: 32448336
Drug: Intramuscular buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular buprenorphine (0.02 mg/kg)
Trial: 32448336
Drug: Subcutaneous buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous buprenorphine (0.02 mg/kg)
Trial: 32448336
Drug: Carprofen (4.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carprofen (4.4 mg/kg SC)
Trial: 34453013
Drug: CHO (Carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO (Carbohydrate drink 1.2 g kg‐1 2 hr‐1)
Trial: 34453013
Drug: CHO +
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO + PRO (Carbohydrate drink with whey protein concentrate 0.3 g kg‐1 2 hr‐1)
Trial: 34453013
Drug: CHO +
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO + PROH (Carbohydrate drink with whey protein hydrolysate 0.3 g kg‐1 2 hr‐1)
Trial: 32620104
Drug: Melissa officinalis
RxNorm normalized name: melissa officinalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melissa officinalis (2 g)
Trial: 32620104
Drug: Lavandula angustifolia
RxNorm normalized name: Lavandula Angustifolia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lavandula angustifolia (2 g)
Trial: 34424165
Drug: Ring Screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ring Screening (RS) with niclosamide treatment
Trial: 34424165
Drug: Ring Treatment
RxNorm normalized name: RING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ring Treatment (RT) with presumptive niclosamide treatment
Trial: 34424165
Drug: Mass Treatment
RxNorm normalized name: Masse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass Treatment (MT) with niclosamide treatment every 6 months
Trial: 36107229
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron (ferric derisomaltose)
Trial: 36107229
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (ferrous fumarate)
Trial: 32912462
Drug: UFR-guided hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFR-guided hydration (hydration controlled by the RenalGuard System to reach UFR ≥300 ml/h)
Trial: 32912462
Drug: LVEDP-guided hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LVEDP-guided hydration (normal saline infusion rate adjusted according to LVEDP)
Trial: 33355918
Drug: Proton beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton beam therapy
Trial: 35147535
Drug: Integrated Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Care Pathway including a sequential pharmacological algorithm and structured behavioral interventions
Trial: 33105345
Drug: Pelvic radiation
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic radiation therapy (RT)
Trial: 33105345
Drug: No pelvic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pelvic radiation therapy (no-RT)
Trial: 32818949
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) intravenous infusion
Trial: 32660261
Drug: Scapular exercise
RxNorm normalized name: Haemophilus capsular oligosaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scapular exercise with cognitive functional therapy
Trial: 35861974
Drug: Intravitreal rt‐PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal rt‐PA injection before vitrectomy
Trial: 36127726
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 100 µg/25 µg once daily for 14 days
Trial: 33513483
Drug: 10 ng/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ng/L TPT + 0.4% FOS
Trial: 33513483
Drug: 10 ng/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ng/L TPT + 0.8% FOS
Trial: 33513483
Drug: 10 ng/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ng/L TPT
Trial: 33860672
Drug: Midodrine 10
RxNorm normalized name: midodrine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine 10 mg three-times a day for 5 days
Trial: 35973473
Drug: Sporopollenin exine
RxNorm normalized name: oxine
DrugBank: Oxyquinoline (DB11145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sporopollenin exine capsules (SpECs) containing vitamin D
Trial: 33774956
Drug: Oral omega
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral omega 3 in standard dose along with oral isotretinoin
Trial: 33774956
Drug: Placebo along
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo along with oral isotretinoin
Trial: 36149730
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy (Group 1)
Trial: 36149730
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy and mobile health agent (Group 2)
Trial: 36149730
Drug: Mobile health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile health agent (Group 3)
Trial: 36149730
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Group 4)
Trial: 33430476
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (therapy on dry land and aquatic therapy with Ai Chi)
Trial: 33430476
Drug: Dry land
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dry land therapy (control group)
Trial: 35042175
Drug: Intravaginal (IV)
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal (IV) PGE2 (2 mg)
Trial: 35042175
Drug: Intracervical (IC)
RxNorm normalized name: eladocagene exuparvovec
DrugBank: Eladocagene exuparvovec (DB16780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical (IC) PGE2 (0.5 mg)
Trial: 35918438
Drug: Ultrasound-guided bilateral
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided bilateral serratus anterior plane block (SAPB) with 3 mg/kg 0.25% ropivacaine
Trial: 35918438
Drug: Incision infiltration
RxNorm normalized name: INCISED NOTOPTERYGIUM RHIZOME OR ROOT (NOTOPTERYGIUM FRANCHETII)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incision infiltration (II) with 3 mg/kg 0.75% ropivacaine
Trial: 35246048
Drug: NTI (Nociceptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTI (Nociceptive Trigeminal Inhibition) oral device
Trial: 34081923
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV vaccine recipients
Trial: 34081923
Drug: Bivalent HPV
RxNorm normalized name: HPV, bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent HPV vaccine recipients
Trial: 33590594
Drug: Vibration stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration stimulation during intramuscular injection
Trial: 33590594
Drug: Standard intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intramuscular injection without vibration stimulation
Trial: 35725523
Drug: Budesonide 256
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 256 µg/day
Trial: 34132695
Drug: Early prehospital
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early prehospital tranexamic acid (TXA) administered within 1 hour from time of injury
Trial: 34132695
Drug: Delayed prehospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed prehospital tranexamic acid (TXA) administered beyond 1 hour from time of injury
Trial: 32706639
Drug: Neoadjuvant chemohormonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemohormonal therapy (CHT) with androgen deprivation plus docetaxel (75 mg/m2 every 3 weeks for 6 cycles) and radical prostatectomy (RP)
Trial: 36041750
Drug: Sotatercept 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotatercept 0.3 or 0.7 mg·kg‐1 (placebo-crossed group)
Trial: 33436053
Drug: Jin’s three‐needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jin’s three‐needle acupuncture (JTN) combined with mirror therapy (MT)
Trial: 35240478
Drug: Emergency medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergency medicine journals
Trial: 33962499
Drug: Herbal supplement
RxNorm normalized name: LYDIA PINKHAM Herbal Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal supplement (Combi-5) taken along with vitamin C and Zinc supplements
Trial: 35565744
Drug: 8% trehalose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% trehalose solution
Trial: 35565744
Drug: 6% trehalose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% trehalose solution